Fortitude Family Office’s DataMeds AI MEDS Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDS
TRCT
GRP
DB
Fortitude Family Office's MEDS Position: Q2 2026 in Review
Fortitude Family Office opened a new position in DataMeds AI (MEDS) in Q2 2026: 118 shares worth $366. The stake represents ﹤0.01% of the portfolio and ranks #2023 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in MEDS as recently as Q4 2025.
Fortitude Family Office first reported a position in MEDS in Q4 2025 and has held it in 2 quarters since. The position peaked at $607 in Q4 2025. 9 funds tracked by Wall St. Rank hold MEDS as of Q2 2026.
- Fortitude Family Office held 118 shares of DataMeds AI worth $366 as of Q2 2026.
- DataMeds AI was a new Fortitude Family Office position in Q2 2026.
- DataMeds AI made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #2023 holding.
- Fortitude Family Office first reported a position in DataMeds AI in Q4 2025 and has held it in 2 quarters since.
- Fortitude Family Office's DataMeds AI position peaked at $607 in Q4 2025.
- 9 funds tracked by Wall St. Rank held DataMeds AI as of Q2 2026.
Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.